Biomerica share price today

(BMRA)

Biomerica share price is $0.28 & ₹23.86 as on 25 Dec 2024, 2.30 'hrs' IST

$0.28

▲

0.01

(2.21%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Biomerica share price in Dollar and Rupees. Guide to invest in Biomerica from India. Also see the sentimental analysis on Indian investors investing in Biomerica. Get details on the Indian mutual funds that are investing in Biomerica. Get Analyst recommendations and forecasts along with all the Biomerica's financials.

Biomerica share price movements

Today's Low: $0.27
Today's High: $0.28
$0.28
3.57%
Downside
Day's Volatility :3.57%
Upside
0.0%
52 Weeks Low: $0.24
52 Weeks High: $1.35
$0.28
13.75%
Downside
52 Weeks Volatility :82.11%
Upside
79.26%

Biomerica Returns

Period	Biomerica Inc	Index (Russel 2000)
3 Months	-15.76%	0.0%
6 Months	-38.15%	0.0%
1 Year	-76.83%	0.0%
3 Years	-93.3%	-21.1%

Biomerica Key Statistics

in dollars & INR

Previous Close	$0.272
Open	$0.27
Today's High	$0.28
Today's Low	$0.27
Market Capitalization	$5.5M
Today's Volume	$50.8K
52 Week High	$1.35
52 Week Low	$0.2415
Revenue TTM	$5.5M
EBITDA	$-6.4M
Earnings Per Share (EPS)	$-0.37
Profit Margin	-111.85%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-76.48%

How to invest in Biomerica from India?

It is very easy for Indian residents to invest directly in Biomerica from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Biomerica stock in both Indian Rupees (INR) and US Dollars (USD). Search for Biomerica or BMRA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Biomerica or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Biomerica shares which would translate to 3.043 fractional shares of Biomerica as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Biomerica, in just a few clicks!

Returns in Biomerica for Indian investors in Rupees

Investment Value

₹1,00,000

Biomerica investment value today

Current value as on today

₹25,572

Returns

₹74,428

(-74.43%)

Returns from Biomerica Stock

₹76,667 (-76.67%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Biomerica

580.0%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Biomerica from India has grown in the last 30 days as on Dec 26, 2024. 580.0% more purchase transactions for Biomerica in the last 30 days versus the previous period.

128%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Biomerica on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 128% more investors are searching Biomerica in the last 30 days versus the previous period.

Global Institutional Holdings in Biomerica

Granahan Investment Management Inc..
3.14%
Acadian Asset Management LLC
1.34%
Vanguard Group Inc
1.00%
BlackRock Inc
0.89%
Geode Capital Management, LLC
0.74%
UBS Group AG
0.55%

Analyst Recommendation on Biomerica

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Biomerica(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Biomerica

What analysts predicted

Upside of 4542.86%

Current:

$0.28

Target:

$13.00

Insights on Biomerica

Price Movement
In the last 1 year, BMRA stock has moved down by -76.8%
Increasing Revenue
Revenue is up for the last 3 quarters, 1.01M → 1.80M (in $), with an average increase of 23.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -1.91M → -1.31M (in $), with an average increase of 21.5% per quarter
BMRA vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 62.7% return, outperforming this stock by 139.5%
BMRA vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 113.2% return, outperforming this stock by 206.6%
Price to Sales
ForBMRA every $1 of sales, investors are willing to pay $0.9, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Biomerica Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$5.2M	↓ 6.53%
Net Income	$-2.4M	↑ 63.26%
Net Profit Margin	-46.01%	↓ 19.67%

	FY20	Y/Y Change
Revenue	$6.7M	↑ 28.69%
Net Income	$-2.3M	↓ 2.26%
Net Profit Margin	-34.95%	↑ 11.06%

	FY21	Y/Y Change
Revenue	$7.2M	↑ 7.57%
Net Income	$-6.5M	↑ 176.57%
Net Profit Margin	-89.86%	↓ 54.91%

	FY22	Y/Y Change
Revenue	$18.9M	↑ 162.14%
Net Income	$-4.5M	↓ 29.96%
Net Profit Margin	-24.01%	↑ 65.85%

	FY23	Y/Y Change
Revenue	$5.3M	↓ 71.71%
Net Income	$-7.1M	↑ 57.58%
Net Profit Margin	-133.73%	↓ 109.72%

	FY24	Y/Y Change
Revenue	$5.4M	↑ 1.42%
Net Income	$-6.0M	↓ 16.27%
Net Profit Margin	-110.4%	↑ 23.33%

	Q2 FY23	Q/Q Change
Revenue	$1.1M	↓ 0.29%
Net Income	$-1.8M	↑ 8.63%
Net Profit Margin	-161.72%	↓ 13.28%

	Q3 FY23	Q/Q Change
Revenue	$1.7M	↑ 54.57%
Net Income	$-1.1M	↓ 36.84%
Net Profit Margin	-66.08%	↑ 95.64%

	Q4 FY23	Q/Q Change
Revenue	$1.6M	↓ 8.52%
Net Income	$-1.5M	↑ 33.13%
Net Profit Margin	-96.17%	↓ 30.09%

	Q1 FY24	Q/Q Change
Revenue	$1.0M	↓ 35.1%
Net Income	$-1.9M	↑ 27.27%
Net Profit Margin	-188.59%	↓ 92.42%

	Q2 FY24	Q/Q Change
Revenue	$1.1M	↑ 9.73%
Net Income	$-1.4M	↓ 25.91%
Net Profit Margin	-127.33%	↑ 61.26%

	Q3 FY24	Q/Q Change
Revenue	$1.8M	↑ 61.92%
Net Income	$-1.3M	↓ 7.39%
Net Profit Margin	-72.83%	↑ 54.5%

	FY19	Y/Y Change
Profit	$1.3M	↓ 26.36%

	FY20	Y/Y Change
Profit	$1.8M	↑ 37.91%

	FY21	Y/Y Change
Profit	$497.0K	↓ 72.11%

	FY22	Y/Y Change
Profit	$3.0M	↑ 499.1%

	FY23	Y/Y Change
Profit	$446.0K	↓ 85.02%

	FY24	Y/Y Change
Profit	$611.0K	↑ 37.0%

	Q2 FY23	Q/Q Change
Profit	$28.8K	↓ 76.05%

	Q3 FY23	Q/Q Change
Profit	$412.0K	↑ 1330.21%

	Q4 FY23	Q/Q Change
Profit	$325.0K	↓ 21.12%

	Q1 FY24	Q/Q Change
Profit	$-149.0K	↓ 145.85%

	Q2 FY24	Q/Q Change
Profit	$20.0K	↓ 113.42%

	Q3 FY24	Q/Q Change
Profit	$289.0K	↑ 1345.0%

	FY19	Y/Y Change
Operating Cash Flow	$-2.2M	↑ 91.11%
Investing Cash Flow	$-171.1K	↑ 31.27%
Financing Cash Flow	$1.9M	↑ 47.37%

	FY20	Y/Y Change
Operating Cash Flow	$-4.3M	↑ 91.51%
Investing Cash Flow	$-118.9K	↓ 30.5%
Financing Cash Flow	$12.4M	↑ 548.73%

	FY21	Y/Y Change
Operating Cash Flow	$-5.3M	↑ 22.2%
Investing Cash Flow	$-295.6K	↑ 148.54%
Financing Cash Flow	$1.1M	↓ 91.0%

	FY22	Y/Y Change
Operating Cash Flow	$-480.5K	↓ 90.85%
Investing Cash Flow	$-170.3K	↓ 42.37%
Financing Cash Flow	$2.4M	↑ 115.0%

	FY23	Y/Y Change
Operating Cash Flow	$-5.5M	↑ 1039.15%
Investing Cash Flow	$-78.0K	↓ 54.21%
Financing Cash Flow	$9.4M	↑ 292.15%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-962.7K	↓ 44.19%
Investing Cash Flow	$-14.1K	↑ 145.4%
Financing Cash Flow	$7.3M	↑ 29595.41%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-1.7M	↑ 73.89%
Investing Cash Flow	$-63.0K	↑ 345.54%
Financing Cash Flow	$-71.0K	↓ 100.97%

Biomerica Technicals Summary

Sell

Neutral

Buy

Biomerica is currently in a neutral trading position according to technical analysis indicators.

Biomerica Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Biomerica Inc	-8.13%	-38.15%	-76.83%	-93.3%	-90.31%
Stryker Corporation	-4.86%	8.88%	24.0%	37.11%	77.64%
Boston Scientific Corp.	0.95%	18.27%	62.57%	111.2%	102.42%
Edwards Lifesciences Corp.	5.35%	-19.24%	-1.09%	-42.27%	-2.7%
Abbott Laboratories	-2.71%	9.66%	4.53%	-18.87%	32.21%
Medtronic Plc	-4.83%	2.79%	-1.07%	-21.92%	-27.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Biomerica Inc	NA	NA	0.0	0.0	-0.76	-0.39	NA	0.32
Stryker Corporation	39.7	39.7	2.56	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	75.26	75.26	1.65	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	29.1	29.1	6.92	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.88	34.88	2.22	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.94	24.94	1.49	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Biomerica Inc	Buy	$5.5M	-90.31%	NA	-111.85%
Stryker Corporation	Buy	$141.3B	77.64%	39.7	16.34%
Boston Scientific Corp.	Buy	$134.2B	102.42%	75.26	11.26%
Edwards Lifesciences Corp.	Buy	$44.5B	-2.7%	29.1	65.86%
Abbott Laboratories	Buy	$199.0B	32.21%	34.88	13.99%
Medtronic Plc	Buy	$104.6B	-27.8%	24.94	12.06%

About Biomerica

biomerica, inc. (www.biomerica.com) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. the company’s products are designed to enhance health and well-being, while reducing total healthcare costs. biomerica primarily focuses on products for gastrointestinal disease, diabetes and esoteric testing. the biomerica infoods® ibs product identifies patient specific foods that when removed may alleviate an individual's ibs symptoms. this patent pending diagnostic guided therapy is designed to allow for a patient specific guided dietary regimen to improve irritable bowel syndrome (ibs) outcomes. the point-of-care product is being developed to allow physicians to perform the test in-office using a finger stick blood sample while a clinical lab version of the product will be the first for wh

Organization	Biomerica
Employees	64
CEO	Mr. Zackary S. Irani
Industry	Health Technology

Management People of Biomerica

Name	Title
Mr. Zackary S. Irani	CEO & Director
Mr. Allen C. Barbieri	Executive Vice-Chairman of the Board & Corporate Secretary
Mr. Gary Lu CPA	Principal Accounting Officer & CFO
Ms. Lucy Liu Ph.D.	Director of Manufacturing & Technical Operations

Important FAQs about investing in Biomerica from India :

What is Biomerica share price today?

Biomerica share price today stands at $0.28, Open: $0.27 ; Previous Close: $0.27 ; High: $0.28 ; Low: $0.27 ; 52 Week High: $1.35 ; 52 Week Low: $0.24. The stock opens at $0.27, after a previous close of $0.27. The stock reached a daily high of $0.28 and a low of $0.27, with a 52-week high of $1.35 and a 52-week low of $0.24.

Can Indians buy Biomerica shares?

Yes, Indians can invest in the Biomerica (BMRA) from India.

With INDmoney, you can buy Biomerica at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Biomerica at zero transaction cost.

How can I buy Biomerica shares from India?

It is very easy to buy Biomerica from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biomerica be purchased?

Yes, you can buy fractional shares of Biomerica with INDmoney app.

What are the documents required to start investing in Biomerica stocks?

To start investing in Biomerica, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.